Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty

Overview of attention for article published in Vascular Health and Risk Management, February 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 49 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 3,351 followers.

Bivalirudin for ST elevation myocardial infarction angioplasty http://t.co/22PLI3Fk #dovepress

Reply Repost Favourite